In a move that will provide a big impetus to India's $500-million clinical trial industry, which has of late seen stunted growth, the government on Thursday cleared around 55 trials proposed by pha

Drug regulator has set a range of . 4 lakh to . 74 lakh as payout, depending on age and health risks of volunteers

An expert panel set up by the drug regulator has recommended a minimum compensation of . 2 lakh for the family of ‘most serious, terminally ill’ patients who die because of drug study-related injuries.

New vaccine comes with company's own R&D involving an eight-year long effort and Rs 65 crore investment.

The Supreme Court on Tuesday decided to examine the new National Pharmaceutical Pricing Policy-2012 for fixing prices of essential medicines in the country and also the Drugs (Prices Control) Order

Bangalore: Several US and Canadian companies have stopped clinical trials in India following an amendment to the rules which, they say, could lead to “unreasonable claims” by subject-patients.

Pharma companies oppose vociferously 45 days' time period given to them for replacing existing stocks

Taking their cue from Cipla and Alembic, many in the pharmaceutical industry have challenged the new drug price fixation orders that were to be implemented from July 29. The move is expected to delay the introduction of low-priced medicines in the market.